Title of article :
A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions
Author/Authors :
Gregg W. Stone، نويسنده , , Paul S. Teirstein، نويسنده , , Ronald Rubenstein، نويسنده , , Dwayne Schmidt، نويسنده , , Patrick L. Whitlow، نويسنده , , Edward J. Kosinski، نويسنده , , Gregory Mishkel، نويسنده , , John A. Power، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2002
Abstract :
Objectives
We sought to evaluate the safety and efficacy of percutaneous transmyocardial revascularization (PTMR) in patients with refractory angina caused by one or more chronic total occlusions (CTOs) of a native coronary artery.
Background
Previous unblinded, randomized trials of PTMR in patients with end-stage coronary artery disease and refractory angina have demonstrated significant relief of angina and increased exercise duration. Whether such benefits would be realized in blinded patients with less extensive coronary artery disease is unknown.
Methods
A total of 141 consecutive patients with class III or IV angina caused by one or more chronically occluded native coronary arteries in which a percutaneous coronary intervention (PCI) had failed were prospectively randomized, at 17 medical centers, in the same procedure, to PTMR plus maximal medical therapy (MMT) (n = 71) or MMT only (n = 70). Blinding was achieved through heavy sedation, dark goggles and the concurrent performance of PCI in all patients.
Results
Baseline characteristics were similar between the two groups. A median number of 20 laser channels were created in patients randomized to PTMR. At six months, the anginal class improved by two or more classes in 49% of patients assigned to PTMR and in 37% of those assigned to MMT (p = 0.33). The median increase in exercise duration from baseline to six months was 64 s with PTMR versus 52 s with MMT (p = 0.73). There were no differences in the six-month rates of death (8.6% vs. 8.8%), myocardial infarction (4.3% vs. 2.9%) or any revascularization (4.3% vs. 5.9%) in the PTMR and MMT groups, respectively (p = NS for all).
Conclusions
In patients with class III or IV angina caused by nonrecanalizable CTOs, the performance of PTMR does not result in a greater reduction in angina, improvement in exercise duration or survival free of adverse cardiac events, as compared with MMT only.
Keywords :
Direct myocardial revascularization In Regeneration of Endomyocardial Channels Trial , myocardial infarction , MMT , maximal medical therapy , Percutaneous coronary intervention , PTMR , percutaneous transmyocardial revascularization , PCI , yttrium aluminum garnet , YAG , CABG , Coronary Artery Bypass Graft Surgery , CTO , Direct , chronic total occlusion , MI
Journal title :
JACC (Journal of the American College of Cardiology)
Journal title :
JACC (Journal of the American College of Cardiology)